NCT03551626
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03551626
Title Study of Dabrafenib+Trametinib in the Adjuvant Treatment of Stage III BRAF V600+ Melanoma After Complete Resection to Evaluate the Impact on Pyrexia Related Outcomes (COMBI-APlus)
Acronym COMBI-APlus
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries TUR | SWE | SVN | SVK | POL | NOR | LVA | LTU | ITA | ISR | HUN | GRC | GBR | FRA | FIN | CZE | CAN | BRA | AUS | ARG

Facility Status City State Zip Country Details
Novartis Investigative Site Rosario Sante Fe S200KZE Argentina Details
Novartis Investigative Site Buenos Aires C1125ABE Argentina Details
Novartis Investigative Site Córdoba X5004BAL Argentina Details
Novartis Investigative Site Woolloongabba Queensland 4102 Australia Details
Novartis Investigative Site Cairns QLD 4870 Australia Details
Novartis Investigative Site Rio de Janeiro Rio de Janeiro 20220410 Brazil Details
Novartis Investigative Site Porto Alegre Rio Grande do Sul 90035-003 Brazil Details
Novartis Investigative Site São Paulo São Paulo 01246 000 Brazil Details
Novartis Investigative Site Calgary Alberta T2N 4N2 Canada Details
Novartis Investigative Site Edmonton Alberta T6G 1Z2 Canada Details
Novartis Investigative Site Hamilton Ontario L8V 5C2 Canada Details
Novartis Investigative Site London Ontario N6A 4L6 Canada Details
Novartis Investigative Site Ottawa Ontario K1H 8L6 Canada Details
Novartis Investigative Site Toronto Ontario M4N 3M5 Canada Details
Novartis Investigative Site Toronto Ontario M5G 1Z6 Canada Details
Novartis Investigative Site Montreal Quebec H3T 1E2 Canada Details
Novartis Investigative Site Québec Quebec G1R 2J6 Canada Details
Novartis Investigative Site Brno Czech Republic 656 53 Czechia Details
Novartis Investigative Site Prague Czech Republic 180 00 Czechia Details
Novartis Investigative Site Zlín Czech Republic 762 75 Czechia Details
Novartis Investigative Site Hradec Králové CZE 500 05 Czechia Details
Novartis Investigative Site Ostrava Poruba 708 52 Czechia Details
Novartis Investigative Site Prague Prague 1 11000 Czechia Details
Novartis Investigative Site Olomouc 779 00 Czechia Details
Novartis Investigative Site Prague 12808 Czechia Details
Novartis Investigative Site Helsinki 9 Finland Details
Novartis Investigative Site Tampere FIN-33521 Finland Details
Novartis Investigative Site Turku 20520 Finland Details
Novartis Investigative Site Pierre-Bénite Cedex 02 69495 France Details
Novartis Investigative Site Limoges Haute Vienne 87000 France Details
Novartis Investigative Site Rennes Ille Et Vilaine 35062 France Details
Novartis Investigative Site Besançon 25030 France Details
Novartis Investigative Site Bobigny 93009 France Details
Novartis Investigative Site Bordeaux 33075 France Details
Novartis Investigative Site Boulogne-Billancourt 92104 France Details
Novartis Investigative Site Clermont-Ferrand 63003 France Details
Novartis Investigative Site Dijon 21034 France Details
Novartis Investigative Site Grenoble 38043 France Details
Novartis Investigative Site Lille 59037 France Details
Novartis Investigative Site Lorient 56322 France Details
Novartis Investigative Site Marseille 13885 France Details
Novartis Investigative Site Montpellier 34295 France Details
Novartis Investigative Site Nice 06202 France Details
Novartis Investigative Site Paris 75475 France Details
Novartis Investigative Site Poitiers 86021 France Details
Novartis Investigative Site Reims 51092 France Details
Novartis Investigative Site Toulouse 31059 France Details
Novartis Investigative Site Villejuif 94800 France Details
Novartis Investigative Site Athens 115 27 Greece Details
Novartis Investigative Site Athens 18547 Greece Details
Novartis Investigative Site Athens GR 115 22 Greece Details
Novartis Investigative Site Thessaloniki 54622 Greece Details
Novartis Investigative Site Budapest H 1122 Hungary Details
Novartis Investigative Site Pécs 7623 Hungary Details
Novartis Investigative Site Szeged H 6725 Hungary Details
Novartis Investigative Site Jerusalem 9112001 Israel Details
Novartis Investigative Site Ramat Gan 52621 Israel Details
Novartis Investigative Site Bergamo BG 24127 Italy Details
Novartis Investigative Site Meldola FC 47014 Italy Details
Novartis Investigative Site Antella - Bagno A Ripoli FI 50011 Italy Details
Novartis Investigative Site Genova GE 16132 Italy Details
Novartis Investigative Site Milan MI 20133 Italy Details
Novartis Investigative Site Milan MI 20141 Italy Details
Novartis Investigative Site Modena MO 41124 Italy Details
Novartis Investigative Site Palermo PA 90127 Italy Details
Novartis Investigative Site Padua PD 35100 Italy Details
Novartis Investigative Site Roma RM 00128 Italy Details
Novartis Investigative Site Roma RM 00167 Italy Details
Novartis Investigative Site Torino TO 10126 Italy Details
Novartis Investigative Site Udine UD 33100 Italy Details
Novartis Investigative Site Napoli 80131 Italy Details
Novartis Investigative Site Sapporo Hokkaido 060-8543 Japan Details
Novartis Investigative Site Chuo Ku Tokyo 104 0045 Japan Details
Novartis Investigative Site Riga LV 1079 Latvia Details
Novartis Investigative Site Vilnius LT-08660 Lithuania Details
Novartis Investigative Site Ålesund NO-6026 Norway Details
Novartis Investigative Site Oslo 0379 Norway Details
Novartis Investigative Site Gdansk 80 952 Poland Details
Novartis Investigative Site Warsaw 02 781 Poland Details
Novartis Investigative Site Wroclaw 53 413 Poland Details
Novartis Investigative Site Porto 4200-072 Portugal Details
Novartis Investigative Site Moscow 115478 Russia Details
Novartis Investigative Site Moscow Region Istra Village 143423 Russia Details
Novartis Investigative Site Omsk 644013 Russia Details
Novartis Investigative Site Saint Petersburg 197758 Russia Details
Novartis Investigative Site Bratislava 812 50 Slovakia Details
Novartis Investigative Site Košice 04191 Slovakia Details
Novartis Investigative Site Ljubljana 1000 Slovenia Details
Novartis Investigative Site Gothenburg SE-413 45 Sweden Details
Novartis Investigative Site Örebro 701 85 Sweden Details
Novartis Investigative Site Stockholm SE 171 76 Sweden Details
Novartis Investigative Site Umeå SE 901 85 Sweden Details
Novartis Investigative Site Izmir 35040 Turkey (Türkiye) Details
Novartis Investigative Site Bristol Avon BS2 8ED United Kingdom Details
Novartis Investigative Site Northwood Middlesex HA6 2RN United Kingdom Details
Novartis Investigative Site Sheffield South Yorkshire S10 2JF United Kingdom Details
Novartis Investigative Site Cambridge CB2 2QQ United Kingdom Details
Novartis Investigative Site Leeds LS9 7TF United Kingdom Details
Novartis Investigative Site Manchester M20 4BX United Kingdom Details
Novartis Investigative Site Southampton SO16 6YD United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field